The FAO inhibitor etomoxir and FABP5 deficiency have proven effective in counterbalancing the impact of NSUN2 upregulation on FA metabolism and the proliferation, migration, and invasion of osteosarcoma 143b cells. Here, FABP5 is linked to osteosarcoma.